E.P. Mamounas

5.0k citations

18 papers · 3.7k indexed · 2 hit papers · h-index 11

Cancer Research top 0.2%
- Breast Cancer Treatment Studies 11
- Cancer Genomics and Diagnostics 2
Pathology and Forensic Medicine top 0.5%
- Genetic factors in colorectal cancer 2
Oncology top 1%
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 4
- HER2/EGFR in Cancer Research 3
- Cancer Cells and Metastasis 2
Radiology, Nuclear Medicine and Imaging top 5%
Surgery top 5%
- Colorectal and Anal Carcinomas 2

Co-authors: Bernard Fisher Norman Wolmark Richard G. Margolese Edwin R. Fisher James L. Hoehn Anatolio B. Cruz A Brown N V Dimitrov
Cited by: Cancer Research Pathology and Forensic Medicine Oncology
Journals: The Lancet (1 paper)Journal of Clinical Oncology (4 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
Partner nations: United States Belgium Canada

In The Last Decade

E.P. Mamounas

18 papers receiving 3.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by E.P. Mamounas

Since Specialization

Citations

This map shows the geographic impact of E.P. Mamounas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.P. Mamounas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.P. Mamounas more than expected).

Fields of papers citing papers by E.P. Mamounas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.P. Mamounas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.P. Mamounas. The network helps show where E.P. Mamounas may publish in the future.

Co-authorship network

The 25 scholars most cited alongside E.P. Mamounas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with E.P. Mamounas Line = papers co-authored together E.P. Mamounas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Effect of preoperative chemotherapy on the outcome of women with operable breast cancer Journal of Clinical Oncology ·Bernard Fisher,John Bryant,Norman Wolmark,E.P. Mamounas,A Brown,Edwin R. Fisher,D. Lawrence Wickerham,Mirsada Begovič,Arthur P. DeCillis,A Robidoux,Richard G. Margolese,Anatolio B. Cruz,James L. Hoehn,Alan Lees,N V Dimitrov,Harry D. Bear	2023	18
2	Peripheral neuropathy (PN), thrombocytopenia (TCP) and central nervous system (CNS) recurrence: An update of the phase III KATHERINE trial of post-neoadjuvant trastuzumab emtansine (T-DM1) or trastuzumab (H) in patients (pts) with residual invasive HER2-positive breast cancer (BC) Annals of Oncology ·Michael Untch,Charles E. Geyer,Chiun‐Sheng Huang,Sibylle Loibl,Norman Wolmark,Max S. Mano,Gϋnter von Minckwitz,Adam Brufsky,X. Pivot,Jonathan Polikoff,Andrea Fontana,Bella Kaufman,Juan Carlos Alcedo,Thomas Boulet,H. Liu,Chuangye Song,E.P. Mamounas	2019	12
3	478 Prognostic Significance of pAKT Plus Estrogen Receptor Status in Adjuvant Cytotoxic Treatment of Breast Cancer European Journal of Cancer ·Sherry X. Yang,KM Kidwell,Joe Costantino,E.P. Mamounas,David Nguyen,C. Kim,Norman Wolmark,Soonmyoung Paik	2012	1
4	Concurrent Bevacizumab with a Sequential Regimen of Doxorubicin and Cyclophosphamide Followed by Docetaxel and Capecitabine as Neoadjuvant Therapy for HER2− Locally Advanced Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group Clinical Breast Cancer ·Priya Rastogi,Marc Buyse,Sandra M. Swain,Samuel A. Jacobs,André Robidoux,Marcia K. Liepman,Eduardo R. Pajon,Philip A. Dy,Juan G. Posada,Marianne K. Melnik,Fanny Piette,Charles E. Geyer,E.P. Mamounas,Norman Wolmark	2011	13
5	Pathologic Complete Response With Six Compared With Three Cycles of Neoadjuvant Epirubicin Plus Docetaxel and Granulocyte Colony-stimulating Factor in Operable Breast Cancer: Results of ABCSG-14 Breast Diseases A Year Book Quarterly ·E.P. Mamounas	2008	6
6	Combined Use of Clinical and Pathologic Staging Variables to Define Outcomes for Breast Cancer Patients Treated With Neoadjuvant Therapy Breast Diseases A Year Book Quarterly ·E.P. Mamounas	2008	8
7	Centralized medical monitoring in phase III clinical trials: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience Clinical Trials ·Atilla Soran,Lois Nesbitt,E.P. Mamounas,BC Lembersky,Jennifer Bryant,Stewart Anderson,Ami Shah Brown,M Passarello	2006	10
8	Pattern of regional failure in patients with breast cancer treated by lumpectomy, breast radiation +/− chemotherapy and/or tamoxifen with no regional radiation: results from 10 NSABP randomized trials International Journal of Radiation OncologyBiologyPhysics ·Alphonse G. Taghian,John Bryant,Stewart Anderson,Melvin Deutsch,E.P. Mamounas,Norman Wolmark,Bernard Fisher	2003	2
9	UFT/leucovorin vs 5-FU/leucovorin in colon cancer. PubMed ·Roy E. Smith,Barry C. Lembersky,Harry S. Wieand,Linda H. Colangelo,E.P. Mamounas	2000	12
10	UFT plus calcium folinate vs 5-FU plus calcium folinate in colon cancer. PubMed ·Rebecca L. Smith,D. L. Wickerham,Harry S. Wieand,Linda H. Colangelo,E.P. Mamounas	1999	11
11	Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.breakdown → Journal of Clinical Oncology ·Bernard Fisher,John Bryant,Norman Wolmark,E.P. Mamounas,A Brown,Edwin R. Fisher,D. Lawrence Wickerham,Mirsada Begovič,Arthur P. DeCillis,A. Robidoux,Richard G. Margolese,Anatolio B. Cruz,James L. Hoehn,Alan Lees,N V Dimitrov,Harry D. Bear	1998	1688
12	Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.breakdown → Journal of Clinical Oncology ·Bernard Fisher,A Brown,E.P. Mamounas,Sam Wieand,A. Robidoux,Richard G. Margolese,Anatolio B. Cruz,Edwin R. Fisher,D. Lawrence Wickerham,Norman Wolmark,Arthur P. DeCillis,James L. Hoehn,Alan Lees,N V Dimitrov	1997	1373
13	NSABP Protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel. PubMed ·E.P. Mamounas	1997	53
14	Future directions in the adjuvant treatment of colon cancer. PubMed ·E.P. Mamounas,Harry S. Wieand,James C. Jones,D. L. Wickerham,Norman Wolmark	1997	7
15	Preoperative chemotherapy: a model for studying the biology and therapy of primary breast cancer. Journal of Clinical Oncology ·Bernard Fisher,E.P. Mamounas	1995	89
16	Patterns of occurrence of second primary non-mammary malignancies in breast cancer patients: results from 1382 consecutive autopsies Surgical Oncology ·E.P. Mamounas,Carlos Perez‐Mesa,R.B. Penetrante,Deborah L. Driscoll,Leslie E. Blumenson,Theodore N. Tsangaris	1993	5
17	Factors affecting outcome in locally advanced breast cancer Surgical Oncology ·Ernesto Roberto Sánchez-Forgach,E.P. Mamounas,James Warneke,D. Driscoll,Leslie E. Blumenson,Theodore N. Tsangaris	1992	3
18	Significance of ipsilateral breast tumour recurrence after lumpectomy The Lancet ·Bernard Fisher,Stewart Anderson,Edwin R. Fisher,Carol Redmond,D. L. Wickerham,Norman Wolmark,E.P. Mamounas,Melvin Deutsch,Richard G. Margolese	1991	423

About E.P. Mamounas

E.P. Mamounas is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 18 papers that have together received 3.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (11 papers), Cancer Treatment and Pharmacology (8 papers), Colorectal Cancer Treatments and Studies (4 papers), HER2/EGFR in Cancer Research (3 papers), Cancer Cells and Metastasis (2 papers), Colorectal and Anal Carcinomas (2 papers), Cancer Genomics and Diagnostics (2 papers) and Genetic factors in colorectal cancer (2 papers). The work is most often cited by research in Cancer Research (3.1k citations), Pathology and Forensic Medicine (1.8k citations) and Oncology (2.0k citations). E.P. Mamounas has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Bernard Fisher, Norman Wolmark, Richard G. Margolese, Edwin R. Fisher, James L. Hoehn, Anatolio B. Cruz, A Brown, N V Dimitrov, D. Lawrence Wickerham and Alan Lees. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact